ENDV
NDONOVO THERAPEUTICS INCstockOTC
EODNov 18, 2026
0.0001USD0.000%(0.00)200,000
ENDV Financials
In Q3 FY 2023 (ended ), NDONOVO THERAPEUTICS INC (ENDV) reported revenue of $1.52K, net income of −$766.17K, operating cash flow of −$65.37K, and assets of $815.76K (filed ).
Loading business breakdowns…